Slow Alzheimer’s diagnoses ‘mean UK patients missing out on experimental treatments’

Alzheimer's patients in the UK are missing out on experimental treatments due to delayed or inaccurate diagnoses, according to Alzheimer's Research UK. This is despite a record high number of Alzheimer's drug trials this year. UK patients are not being enrolled in clinical trials as a result.